Cargando…

The past, current and future epidemiological dynamic of SARS-CoV-2

SARS-CoV-2, the agent of the COVID-19 pandemic, emerged in late 2019 in China, and rapidly spread throughout the world to reach all continents. As the virus expanded in its novel human host, viral lineages diversified through the accumulation of around two mutations a month on average. Different vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balloux, François, Tan, Cedric, Swadling, Leo, Richard, Damien, Jenner, Charlotte, Maini, Mala, van Dorp, Lucy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278178/ https://www.ncbi.nlm.nih.gov/pubmed/35872966 http://dx.doi.org/10.1093/oxfimm/iqac003

Ejemplares similares

Can T Cells Abort SARS-CoV-2 and Other Viral Infections?
por: Swadling, Leo, et al.
Publicado: (2023)

No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2
por: van Dorp, Lucy, et al.
Publicado: (2020)

Genomic epidemiology of the first epidemic wave of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Palestine
por: Qutob, Nouar, et al.
Publicado: (2021)

Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses
por: Tan, Cedric C.S., et al.
Publicado: (2021)

Emergence of genomic diversity and recurrent mutations in SARS-CoV-2
por: van Dorp, Lucy, et al.
Publicado: (2020)

COVID-19, the first pandemic in the post-genomic era
por: van Dorp, Lucy, et al.
Publicado: (2021)

Transmission of SARS-CoV-2 from humans to animals and potential host adaptation
por: Tan, Cedric C. S., et al.
Publicado: (2022)

Metagenomic evidence for a polymicrobial signature of sepsis
por: Tan, Cedric Chih Shen, et al.
Publicado: (2021)

Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2
por: Diniz, Mariana O., et al.
Publicado: (2022)

Q&A: What are pathogens, and what have they done to and for us?
por: Balloux, Francois, et al.
Publicado: (2017)

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
por: Swadling, Leo, et al.
Publicado: (2021)

Large-scale network analysis captures biological features of bacterial plasmids
por: Acman, Mislav, et al.
Publicado: (2020)

Past, current and future
Publicado: (2017)

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
por: Altmann, Daniel M., et al.
Publicado: (2023)

Artificial Cornea: Past, Current, and Future Directions
por: Holland, Gráinne, et al.
Publicado: (2021)

Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease: Past, Present, and Future
por: Tan, Yu-Yan, et al.
Publicado: (2022)

Mathematical epidemiology: Past, present, and future
por: Brauer, Fred
Publicado: (2017)

Epidemiology of dengue: past, present and future prospects
por: Murray, Natasha Evelyn Anne, et al.
Publicado: (2013)

Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future
por: Allison, Karen, et al.
Publicado: (2020)

An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
por: Wing, Peter A. C., et al.
Publicado: (2023)

Antibodies to SARS-CoV-2 and risk of past or future sick leave
por: Dillner, Joakim, et al.
Publicado: (2021)

Neural networks for genetic epidemiology: past, present, and future
por: Motsinger-Reif, Alison A, et al.
Publicado: (2008)

Causal models in epidemiology: past inheritance and genetic future
por: Vineis, Paolo, et al.
Publicado: (2006)

Epidemiology of Japanese encephalitis: past, present, and future prospects
por: Wang, Huanyu, et al.
Publicado: (2015)

Different profiles and epidemiological scenarios: past, present and future
por: Gorla, David E, et al.
Publicado: (2022)

Pharmacotherapies for Obesity: Past, Current, and Future Therapies
por: Ioannides-Demos, Lisa L., et al.
Publicado: (2011)

First-aid at workplace-past, current and future
por: Priolcar, Xivananda
Publicado: (2012)

Past, Current, and Future of Immunotherapies for Prostate Cancer
por: Boettcher, Adeline N., et al.
Publicado: (2019)

Treatment of liver fibrosis: Past, current, and future
por: Zhang, Chun-Ye, et al.
Publicado: (2023)

Antibody tests for identification of current and past infection with SARS‐CoV‐2
por: Deeks, Jonathan J, et al.
Publicado: (2020)

Antibody tests for identification of current and past infection with SARS‐CoV‐2
por: Fox, Tilly, et al.
Publicado: (2022)

Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future
por: Rehman, Mubasher, et al.
Publicado: (2020)

Social and health epidemiology of immigrants in Germany: past, present and future
por: Razum, Oliver, et al.
Publicado: (2016)

Global epidemiology of canine rabies: past, present, and future prospects
por: Taylor, Louise H, et al.
Publicado: (2015)

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
por: Captur, Gabriella, et al.
Publicado: (2022)

Adjuvant Therapy for Melanoma: Past, Current, and Future Developments
por: Testori, Alessandro A. E., et al.
Publicado: (2020)

Metalloid gold clusters – past, current and future aspects
por: Kenzler, Sebastian, et al.
Publicado: (2021)

Current Trends on Solid Dispersions: Past, Present, and Future
por: Malkawi, Ruba, et al.
Publicado: (2022)

From Theory to Practice: Translating Whole-Genome Sequencing (WGS) into the Clinic
por: Balloux, Francois, et al.
Publicado: (2018)

Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
por: Ganesh, Balasubramanian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8dvt5r9n6mirtq518gohvarh0l